Aidapak Recalls Acetaminophen Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling specific acetaminophen tablets that may be mislabeled as multivitamin chew tablets. The error involves a label mixup.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (label mixup) without reported injuries or illnesses, fitting the criteria for moderate severity.
Plain-English summary
Aidapak Services, LLC is recalling Acetaminophen/Aspirin/Caffeine tablets (250 mg/250 mg/65 mg) due to a labeling error. The product, distributed under NDC 46122010478, may be potentially mislabeled as Multivitamin/Multimineral Chew Tablets (NDC 00536344308).
The recall is limited to repacked drugs distributed in Arizona, California, Oregon, and Washington. The affected product has the pedigree code W003722 and an expiration date of 4/30/2014. The mislabeled product has the pedigree code W003714 and an expiration date of 6/26/2014.
Consumers should check their medication for the specific pedigree and expiration dates listed above. If the product matches the description, they should stop using it and contact their pharmacist or the recalling firm for instructions.
The recalled product
- Product
- ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/250 mg/65 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 46122010478
- Manufacturer
- Aidapak Services, LLC
- Hazard
- Affected units
- 100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- ACETAMINOPHEN/ ASPIRIN/ CAFFEINE
- Tablet
- 250 mg/250 mg/65 mg has the following code Pedigree: W003722
- EXP: 4/30/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- SevereInstrumentation Laboratory Recalls HemoslL AcuStar HIT-lgG In Vitro Diagnostic Reagents
FDA (Devices) · 2026-10-21
- LowMagellan LeadCare II Blood Lead Test Kit Recall for Labeling Error
FDA (Devices) · 2026-10-21
- ModerateIn2bones Recalls Partially Threaded Bone Screws Due to Labeling Error
FDA (Devices) · 2026-10-21
- ModerateGore Viabil Short Wire Biliary Endoprosthesis Recalled for Incorrect Length Labeling
FDA (Devices) · 2026-10-21
Similar recalls
- ModerateAidapak Recalls Multivitamin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Aspirin Chew Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- SevereFDA Recalls Mislabeled Acetaminophen, Butalbital, and Caffeine Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Acetaminophen Chew Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Aspirin EC Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Tri-Buffered Aspirin Tablets Due to Labeling Error
FDA (Drugs) · 2014-01-29